← Scroll for more →
PharmaCyte Biotech, Inc. (PMCB)
Biological Products, (No Diagnostic Substances)
Latest Price
$0.33
TTM P/E
--
Normalized P/E
--
TTM Div Yield
--
Fwd Div Yield
--
Book Value
2.56
P/B Ratio
0.13
Institutional Ownership
7.5% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Citadel Advisors LLC | 369.5K | -- | 3.44% | -150.3K | 2026-06-30 |
| Geode Capital Management, LLC | 124.2K | -- | 1.16% | -71.4K | 2026-06-30 |
| Vanguard Capital Management LLC | 56.8K | -- | 0.53% | +5.3K | 2026-06-30 |
| Renaissance Technologies LLC | 38.0K | -- | 0.35% | -18.5K | 2026-06-30 |
| XTX Topco Ltd | 34.2K | -- | 0.32% | -18.2K | 2026-06-30 |
| Northern Trust Corp | 32.6K | -- | 0.30% | -3.0K | 2026-06-30 |
| Jane Street Group, LLC | 30.1K | -- | 0.28% | +18.5K | 2026-06-30 |
| Schonfeld Strategic Advisors LLC | 26.9K | -- | 0.25% | -83 | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 23.5K | -- | 0.22% | -- | 2026-06-30 |
| Equitec Proprietary Markets, LLC | 22.2K | -- | 0.21% | -- | 2026-06-30 |